Cargando…
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development
The inhibitory neurotransmitter γ-aminobutyric acid (GABA) plays an important role in the modulation of neuronal excitability, and a disruption of GABAergic transmission contributes to the pathogenesis of some seizure disorders. Although many currently available antiseizure medications do act at lea...
Autores principales: | Perucca, Emilio, White, H. Steve, Bialer, Meir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10501930/ https://www.ncbi.nlm.nih.gov/pubmed/37603261 http://dx.doi.org/10.1007/s40263-023-01025-4 |
Ejemplares similares
-
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System
por: Perucca, Emilio, et al.
Publicado: (2023) -
Clinically Relevant Interactions Between Ritonavir-Boosted Nirmatrelvir and Concomitant Antiseizure Medications: Implications for the Management of COVID-19 in Patients with Epilepsy
por: Wanounou, Maor, et al.
Publicado: (2022) -
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
por: Perucca, Emilio
Publicado: (2017) -
Tonic GABA(A) Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy
por: Schipper, S., et al.
Publicado: (2015) -
Seizure control in successive pregnancies in Australian women with epilepsy
por: Vajda, Frank J. E., et al.
Publicado: (2022)